Clinical Roundup UCSD researchers focus on persistent opioid use, abuse and toxicity among cancer survivors November 22, 2019Vol.45 No.44
Clinical Roundup In Opdivo + Yervoy vs. Opdivo alone in resected high-risk melanoma and PD-L1 <1% does not meet primary endpoints November 22, 2019Vol.45 No.44
In Brief Harmar Brereton, Dana Dornsife receive NCCS Ellen Stovall Award November 22, 2019Vol.45 No.44
In Brief Timothy Mullett named chair-elect of the American College of Surgeons Commission on Cancer November 22, 2019Vol.45 No.44
Hahn pledges to be guided by “science and data” in considering vape flavor ban if confirmed at FDA November 22, 2019Vol.45 No.44By Alexandria Carolan
Drugs & Targets FDA grants Breakthrough Device Designation for Exact Sciences blood-based test for detection of HCC November 15, 2019Vol.45 No.43
Drugs & Targets FDA accepts BMS application for Opdivo + Yervoy for liver cancer November 15, 2019Vol.45 No.43
